{"id":"oral-resveratrol","safety":{"commonSideEffects":[{"rate":"null","effect":"Gastrointestinal upset"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Resveratrol's activation of SIRT1 has been shown to have anti-inflammatory and anti-aging effects. This is thought to occur through the regulation of various cellular pathways, including those involved in metabolism and stress resistance.","oneSentence":"Resveratrol acts as an activator of SIRT1, a protein that plays a role in cellular regulation and metabolism.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:24:50.336Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cardiovascular disease prevention"}]},"trialDetails":[{"nctId":"NCT07195994","phase":"NA","title":"A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes","status":"RECRUITING","sponsor":"QuickSilver Scientific","startDate":"2026-02-05","conditions":"Prediabetes / Type 2 Diabetes","enrollment":90},{"nctId":"NCT02905799","phase":"PHASE3","title":"Resveratrol in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-11-09","conditions":"Knee Osteoarthritis","enrollment":142},{"nctId":"NCT07397026","phase":"PHASE1","title":"Clinical and Laboratory Evaluation of Resveratrol Loaded Nanoparticles in the Treatment of Periodontitis: A Randomized Controlled Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hagar Ahmed Ali Mohammed Elzain","startDate":"2025-08-09","conditions":"Periodontitis Stage III","enrollment":48},{"nctId":"NCT07393802","phase":"PHASE3","title":"Evaluation of the Anti-Plaque Effect of a Resveratrol-Based Mouthwash Using a 24-Hour Plaque Re-Growth","status":"NOT_YET_RECRUITING","sponsor":"University of Baghdad","startDate":"2026-03","conditions":"Mouthwash, Chlorhexidine, Biofilm Formation","enrollment":20},{"nctId":"NCT02314208","phase":"PHASE2","title":"Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2015-01-08","conditions":"Spastic Paraplegia, Hereditary","enrollment":12},{"nctId":"NCT07100613","phase":"PHASE2","title":"Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus","status":"RECRUITING","sponsor":"University of Palermo","startDate":"2024-09-04","conditions":"Oral Lichen Planus, Oral Lichen Planus Related Stress, Oral Mucosal Disease","enrollment":45},{"nctId":"NCT06585865","phase":"NA","title":"Strength Training and Resveratrol","status":"RECRUITING","sponsor":"Texas Tech University","startDate":"2025-06-13","conditions":"Sarcopenia, Anabolic Resistance","enrollment":36},{"nctId":"NCT06961279","phase":"NA","title":"Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin Resistance","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2013-09-15","conditions":"Obesity","enrollment":38},{"nctId":"NCT03762096","phase":"NA","title":"Short Interval Resveratrol Trial in Cardiovascular Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"MaineHealth","startDate":"2018-03-06","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease","enrollment":40},{"nctId":"NCT06882564","phase":"PHASE3","title":"Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.","status":"RECRUITING","sponsor":"Al-Mustansiriyah University","startDate":"2025-01-05","conditions":"Halitosis, Mouth Disease, Plaque Induced Gingival Disease","enrollment":54},{"nctId":"NCT02690064","phase":"NA","title":"Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Augusta University","startDate":"2015-04","conditions":"Cystic Fibrosis","enrollment":13},{"nctId":"NCT04449198","phase":"EARLY_PHASE1","title":"Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1","status":"RECRUITING","sponsor":"Augusta University","startDate":"2020-10-14","conditions":"Type 1 Diabetes","enrollment":24},{"nctId":"NCT02909686","phase":"NA","title":"Effects of Botanical Microglia Modulators in Gulf War Illness","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2016-07","conditions":"Gulf War Illness","enrollment":36},{"nctId":"NCT06723119","phase":"NA","title":"Effect of Resveratrol Supplementation on Exercise Performance and Recovery","status":"RECRUITING","sponsor":"University of Central Florida","startDate":"2024-10-01","conditions":"Effect of Resveratrol on Performance and Recovery","enrollment":20},{"nctId":"NCT06711263","phase":"NA","title":"Role of Herbal Based Mouthwashes in Plaque Control","status":"NOT_YET_RECRUITING","sponsor":"Ajman University","startDate":"2024-12-20","conditions":"Plaque Induced Gingival Disease","enrollment":80},{"nctId":"NCT03597568","phase":"NA","title":"Resveratrol and Vascular Function in CKD","status":"COMPLETED","sponsor":"Diana Jalal","startDate":"2019-01-01","conditions":"Chronic Kidney Diseases, Endothelial Dysfunction","enrollment":25},{"nctId":"NCT06601049","phase":"NA","title":"Effectiveness of ResArgin on Adult's Body Composition and Health","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Heather Hausenblaus","startDate":"2024-08-15","conditions":"Weight Loss","enrollment":60},{"nctId":"NCT03525379","phase":"PHASE2","title":"Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2017-10-26","conditions":"Congestive Heart Failure Chronic","enrollment":13},{"nctId":"NCT06470061","phase":"PHASE2","title":"RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β","status":"NOT_YET_RECRUITING","sponsor":"Zaparackas and Knepper LTD","startDate":"2024-07","conditions":"Alzheimer Disease, Mild Cognitive Impairment, Cognitive Decline","enrollment":200},{"nctId":"NCT02123121","phase":"PHASE2","title":"Resveratrol to Enhance Vitality and Vigor in Elders","status":"COMPLETED","sponsor":"University of Florida","startDate":"2015-09","conditions":"Mitochondrial Function, Physical Function","enrollment":60},{"nctId":"NCT05761327","phase":"NA","title":"Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Ardahan University","startDate":"2022-06-03","conditions":"Ulcerative Colitis","enrollment":48},{"nctId":"NCT01842399","phase":"PHASE1, PHASE2","title":"Resveratrol and Cardiovascular Health in the Elderly","status":"TERMINATED","sponsor":"National Institute on Aging (NIA)","startDate":"2015-07-14","conditions":"Vascular Resistance, Hypertension","enrollment":73},{"nctId":"NCT01158417","phase":"NA","title":"Resveratrol in Type2 Diabetes and Obesity","status":"TERMINATED","sponsor":"University at Buffalo","startDate":"2008-12","conditions":"Type 2 Diabetes, Obesity, Insulin Resistance","enrollment":15},{"nctId":"NCT04886297","phase":"PHASE3","title":"A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2021-05-01","conditions":"Dyslipidemias","enrollment":168},{"nctId":"NCT01375959","phase":"NA","title":"Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2011-04","conditions":"Impaired Glucose Tolerance","enrollment":38},{"nctId":"NCT04668274","phase":"PHASE1","title":"JOTROL PK, Safety, and Food Effect Assessment","status":"COMPLETED","sponsor":"Jupiter Orphan Therapeutics Inc.","startDate":"2021-01-21","conditions":"Pharmacokinetics, Safety, Food-drug Interaction","enrollment":24},{"nctId":"NCT02523274","phase":"PHASE2","title":"Resveratrol and Exercise to Treat Functional Limitations in Late Life","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-06","conditions":"Aging","enrollment":60},{"nctId":"NCT03090997","phase":"NA","title":"Effect of Resveratrol and Vitamin C on Insulin Resistance Among Postmenopausal Women","status":"UNKNOWN","sponsor":"Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes","startDate":"2018-02-15","conditions":"Postmenopausal, Insulin Resistance","enrollment":45},{"nctId":"NCT04799743","phase":"NA","title":"The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients","status":"UNKNOWN","sponsor":"Hong Kong Baptist University","startDate":"2021-04-01","conditions":"Covid-19","enrollment":30},{"nctId":"NCT04117022","phase":"NA","title":"Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG","status":"UNKNOWN","sponsor":"ZeaVision, LLC","startDate":"2019-09-01","conditions":"Diabetes, Diabetic Retinopathy","enrollment":45},{"nctId":"NCT01321151","phase":"PHASE1, PHASE2","title":"Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2011-03","conditions":"Sports Concussion","enrollment":12},{"nctId":"NCT04723849","phase":"NA","title":"Efficacy Evaluation of a Mixed Compound of Antioxidants in Terms of Endothelium Damage/Function in Pediatric Subjects With Obesity.","status":"COMPLETED","sponsor":"Universita di Verona","startDate":"2019-02-01","conditions":"Childhood Obesity","enrollment":48},{"nctId":"NCT04258306","phase":"NA","title":"Pilot Study to Evaluate the Plasma Profile of Revifast","status":"COMPLETED","sponsor":"Bernard Fioretti","startDate":"2017-10-01","conditions":"Nutrient; Excess, Product Use Issue","enrollment":6},{"nctId":"NCT01476592","phase":"NA","title":"A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2011-12","conditions":"Neuroendocrine Tumor","enrollment":7},{"nctId":"NCT03446625","phase":"PHASE3","title":"Resveratrol as a Preventive Treatment of OHSS","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2018-03-13","conditions":"Infertility","enrollment":70},{"nctId":"NCT00920556","phase":"PHASE2","title":"A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma","status":"TERMINATED","sponsor":"Sirtris, a GSK Company","startDate":"2009-03-30","conditions":"Multiple Myeloma","enrollment":24},{"nctId":"NCT02246660","phase":"NA","title":"RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2015-01","conditions":"Peripheral Arterial Disease","enrollment":66},{"nctId":"NCT03352895","phase":"NA","title":"The Effects of Resveratrol on the Complications of Patients With Hemodialysis","status":"COMPLETED","sponsor":"Dalin Tzu Chi General Hospital","startDate":"2014-11","conditions":"Chronic Kidney Disease","enrollment":36},{"nctId":"NCT01173640","phase":"NA","title":"Resveratrol and Midazolam Metabolism","status":"COMPLETED","sponsor":"University of Washington","startDate":"2010-07","conditions":"Healthy","enrollment":6},{"nctId":"NCT00920803","phase":"PHASE1","title":"A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases","status":"COMPLETED","sponsor":"Sirtris, a GSK Company","startDate":"2008-08-19","conditions":"Neoplasms, Colorectal","enrollment":9},{"nctId":"NCT02216552","phase":"PHASE2, PHASE3","title":"Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2015-08","conditions":"NAFLD, TYPE 2 DIABETES, METABOLIC SYNDROME","enrollment":10},{"nctId":"NCT02944097","phase":"EARLY_PHASE1","title":"Bioavailability of Resveratrol From Vineatrol30 Extract Incorporated Into Micelles","status":"COMPLETED","sponsor":"University of Hohenheim","startDate":"2015-03","conditions":"Safety After Oral Intake, Pharmacokinetics After Oral Intake","enrollment":12},{"nctId":"NCT03097211","phase":"PHASE1","title":"Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2006-07-17","conditions":"Parkinson Disease","enrollment":38},{"nctId":"NCT03094156","phase":"PHASE1","title":"Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2006-04-26","conditions":"Parkinson Disease","enrollment":39},{"nctId":"NCT03095105","phase":"PHASE1","title":"Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2006-01-24","conditions":"Parkinson Disease","enrollment":25},{"nctId":"NCT03095092","phase":"PHASE1","title":"Effect of Food on BIA 6-512 (Trans-resveratrol)","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2005-05-23","conditions":"Parkinson Disease","enrollment":24},{"nctId":"NCT03093389","phase":"PHASE1","title":"Tolerability and Steady-state Pharmacokinetics of BIA 6-512","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2005-05-11","conditions":"Parkinson Disease","enrollment":40},{"nctId":"NCT02095873","phase":"PHASE1, PHASE2","title":"Healthy Aging Through Functional Food","status":"COMPLETED","sponsor":"University of Warwick","startDate":"2014-05","conditions":"Glucose Intolerance, Aortic Stiffness, Vasodilation","enrollment":32},{"nctId":"NCT01489319","phase":"PHASE1","title":"Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)","status":"TERMINATED","sponsor":"Indiana University","startDate":"2012-02","conditions":"Polycystic Ovary Syndrome","enrollment":47},{"nctId":"NCT02947932","phase":"PHASE4","title":"Oral Resveratrol to Prevent Post-ERCP Pancreatitis","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2016-12","conditions":"Pancreatitis, Acute, Gastrointestinal Disease","enrollment":2700},{"nctId":"NCT01768507","phase":"NA","title":"Reresveratrol Administered to Healthy Male Subjects","status":"COMPLETED","sponsor":"Daniel Doberer","startDate":"2011-03","conditions":"Healthy Subjects, Heme Oxygenase","enrollment":10},{"nctId":"NCT01504854","phase":"PHASE2","title":"Resveratrol for Alzheimer's Disease","status":"COMPLETED","sponsor":"Alzheimer's Disease Cooperative Study (ADCS)","startDate":"2012-05","conditions":"Alzheimer's Disease","enrollment":119},{"nctId":"NCT01964846","phase":"NA","title":"Effect of Antioxidant Intake on Cardiovascular Risk","status":"COMPLETED","sponsor":"Laval University","startDate":"2013-10","conditions":"Effect of Resveratrol and Curcumin on Inflammation","enrollment":22},{"nctId":"NCT01321268","phase":"NA","title":"Safety and Efficacy of a Dietary Supplement in Females With Cellulite","status":"TERMINATED","sponsor":"dsm-firmenich Switzerland AG","startDate":"2011-05","conditions":"Cellulite (Orange Peel Skin)","enrollment":8},{"nctId":"NCT01766180","phase":"NA","title":"Cerebrovascular and Cognitive Improvement by Resveratrol (resVida) and Fruitflow-II (CCIRF-II)","status":"UNKNOWN","sponsor":"Neurolgy Institute for Brain Health and Fitness","startDate":"2013-01","conditions":"Memory Impairment","enrollment":80},{"nctId":"NCT02321189","phase":"NA","title":"The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","startDate":"2014-10","conditions":"Eye Disease","enrollment":34},{"nctId":"NCT00654667","phase":"PHASE2","title":"Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2007-05","conditions":"Insulin Resistance","enrollment":""},{"nctId":"NCT00721877","phase":"PHASE1","title":"Resveratrol in Healthy Adult Participants","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-08","conditions":"Healthy, no Evidence of Disease","enrollment":42},{"nctId":"NCT00433576","phase":"PHASE1","title":"Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2006-12","conditions":"Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Stage I Colon Cancer","enrollment":20},{"nctId":"NCT01832584","phase":"NA","title":"Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness and Mood","status":"COMPLETED","sponsor":"Fruitura Bioscience Ltd.","startDate":"2013-04","conditions":"Healthy","enrollment":45},{"nctId":"NCT00256334","phase":"PHASE1","title":"Resveratrol for Patients With Colon Cancer","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2005-07","conditions":"Colon Cancer, Cancer","enrollment":11},{"nctId":"NCT01593605","phase":"NA","title":"Resveratrol-Leucine Metabolite Synergy in Pre-diabetes","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2012-02","conditions":"Impaired Glucose Tolerance","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":68,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"oral resveratrol","genericName":"oral resveratrol","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Resveratrol acts as an activator of SIRT1, a protein that plays a role in cellular regulation and metabolism. Used for Cardiovascular disease prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}